1. Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis. (December 2022) Authors: Viscardi, Giuseppe; Tralongo, Antonino C.; Massari, Francesco; Lambertini, Matteo; Mollica, Veronica; Rizzo, Alessandro; Comito, Francesca; Di Liello, Raimondo; Alfieri, Salvatore; Imbimbo, Martina; Della Corte, Carminia M.; Morgillo, Floriana; Simeon, Vittorio; Lo Russo, Giuseppe; Proto, Claudia... Journal: European journal of cancer Issue: Volume 177(2022) Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer. Issue 12 (20th April 2022) Authors: Spigel, David R.; Faivre-Finn, Corinne; Gray, Jhanelle E.; Vicente, David; Planchard, David; Paz-Ares, Luis; Vansteenkiste, Johan F.; Garassino, Marina C.; Hui, Rina; Quantin, Xavier; Rimner, Andreas; Wu, Yi-Long; Özgüroğlu, Mustafa; Lee, Ki H.; Kato, Terufumi; de Wit, Maike; Kurata, Takayasu; Re... Journal: Journal of clinical oncology Issue: Volume 40:Issue 12(2022) Page Start: 1301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. G48A, a New KRAS Mutation Found in Lung Adenocarcinoma. Issue 7 (July 2016) Authors: Marabese, Mirko; Caiola, Elisa; Garassino, Marina C.; Rastelli, Giulio; Settanni, Giulio; Brugnara, Sonia; Broggini, Massimo; Ganzinelli, Monica Journal: Journal of thoracic oncology Issue: Volume 11:Issue 7(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab. (1st September 2020) Authors: Friedlaender, Alex; Metro, Giulio; Signorelli, Diego; Gili, Alessio; Economopoulou, Panagiota; Roila, Fausto; Banna, Giuseppe; De Toma, Alessandro; Camerini, Andrea; Christopoulou, Athina; Lo Russo, Giuseppe; Banini, Marco; Galetta, Domenico; Jimenez, Beatriz; Collazo-Lorduy, Ana; Calles, Antonio... Journal: Acta oncologica Issue: Volume 59:Number 9(2020) Page Start: 1058 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial. Issue 3 (27th May 2020) Authors: Vernieri, Claudio; Ganzinelli, Monica; Rulli, Eliana; Farina, Gabriella; Bettini, Anna Cecilia; Bareggi, Claudia; Rosso, Lorenzo; Signorelli, Diego; Galli, Giulia; Lo Russo, Giuseppe; Proto, Claudia; Moro, Massimo; Indraccolo, Stefano; Busico, Adele; Sozzi, Gabriella; Torri, Valter; Marabese, Mir... Journal: ESMO open Issue: Volume 5:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial. Issue 3 (27th May 2020) Authors: Vernieri, Claudio; Ganzinelli, Monica; Rulli, Eliana; Farina, Gabriella; Bettini, Anna Cecilia; Bareggi, Claudia; Rosso, Lorenzo; Signorelli, Diego; Galli, Giulia; Lo Russo, Giuseppe; Proto, Claudia; Moro, Massimo; Indraccolo, Stefano; Busico, Adele; Sozzi, Gabriella; Torri, Valter; Marabese, Mir... Journal: ESMO open Issue: Volume 5:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer. (March 2019) Authors: Crinò, Lucio; Bronte, Giuseppe; Bidoli, Paolo; Cravero, Paola; Minenza, Elisa; Cortesi, Enrico; Garassino, Marina C.; Proto, Claudia; Cappuzzo, Federico; Grossi, Francesco; Tonini, Giuseppe; Sarobba, Maria Giuseppina; Pinotti, Graziella; Numico, Gianmauro; Samaritani, Riccardo; Ciuffreda, Libero;... Journal: Lung cancer Issue: Volume 129(2019) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. On target: Rational approaches to KRAS inhibition for treatment of non-small cell lung carcinoma. (October 2021) Authors: Lindsay, Colin R.; Garassino, Marina C.; Nadal, Ernest; Öhrling, Katarina; Scheffler, Matthias; Mazières, Julien Journal: Lung cancer Issue: Volume 160(2021) Page Start: 152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Outpatient palliative care and thoracic medical oncology: Referral criteria and clinical care pathways. (January 2020) Authors: Caraceni, Augusto; Lo Dico, Silvia; Zecca, Ernesto; Brunelli, Cinzia; Bracchi, Paola; Mariani, Luigi; Garassino, Marina C.; Vitali, Milena Journal: Lung cancer Issue: Volume 139(2020) Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non–small cell lung cancer without tumor PD‐L1 expression: A pooled analysis of 3 randomized controlled trials. Issue 22 (11th September 2020) Authors: Borghaei, Hossein; Langer, Corey J.; Paz‐Ares, Luis; Rodríguez‐Abreu, Delvys; Halmos, Balazs; Garassino, Marina C.; Houghton, Baerin; Kurata, Takayasu; Cheng, Ying; Lin, Jianxin; Pietanza, M. Catherine; Piperdi, Bilal; Gadgeel, Shirish M. Journal: Cancer Issue: Volume 126:Issue 22(2020) Page Start: 4867 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗